RxDoctor Payments Data

Tara Creech

Physician Assistant · Flagstaff, AZNPI 1184275851

Payments from drug & device makers

$1,090in general payments, 2019–2025

Across 50 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Antares Pharma, Inc.$310
  • AbbVie$276
  • Boehringer Ingelheim$129
  • Lilly USA, LLC$115
  • Bausch Health US, LLC$54
  • Biohaven Pharmaceutical Holding Company Ltd.$54
  • plus $152 from 6 others

What the payments were for

  • Food & beverage$1,090100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,090 in reported general payments places this provider in the 70th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$82,569
Medicare patients
265
Services billed
1,009

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide76$82,957
EliquisApixaban24$30,892
XareltoRivaroxaban15$24,403
ProliaDenosumab11$19,909
Rosuvastatin Calcium224$4,083
Levothyroxine Sodium364$3,955
Qvar RedihalerBeclomethasone Dipropionate13$3,743
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$3,109
Fluticasone Propionate HfaFluticasone Propionate12$3,103
Atorvastatin Calcium266$2,372
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,041
Baclofen54$2,035
SynthroidLevothyroxine Sodium26$1,873
Losartan Potassium196$1,829
Albuterol Sulfate HfaAlbuterol Sulfate54$1,822

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$25$82,95776 claims
AbbVieSynthroid$276$1,87326 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Flagstaff

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →